K, P., RJ, M., S, T., Y, L., JH, W., S, S., . . . Jr, J. J. (2026). Lipoprotein(a) and Outcomes in Worsening Heart Failure With Preserved Ejection Fraction: The PARAGLIDE-HF Trial. JACC. Heart failure, 14(5), 102843. https://doi.org/10.1016/j.jchf.2025.102843
Chicago Style (17th ed.) CitationK, Paruchuri, Mentz RJ, Tsimikas S, Liu Y, Ward JH, Sarwat S, Paquette C, Natarajan P, and Januzzi JL Jr. "Lipoprotein(a) and Outcomes in Worsening Heart Failure With Preserved Ejection Fraction: The PARAGLIDE-HF Trial." JACC. Heart Failure 14, no. 5 (2026): 102843. https://doi.org/10.1016/j.jchf.2025.102843.
MLA (9th ed.) CitationK, Paruchuri, et al. "Lipoprotein(a) and Outcomes in Worsening Heart Failure With Preserved Ejection Fraction: The PARAGLIDE-HF Trial." JACC. Heart Failure, vol. 14, no. 5, 2026, p. 102843, https://doi.org/10.1016/j.jchf.2025.102843.